U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT06941792) titled 'Inclisiran Effectiveness in China: a Pragmatic Randomized Trial' on March 06.
Brief Summary: The current study will be conducted to evaluate the real-world effectiveness of inclisiran relative to standard of care (SoC) in Chinese patients with coronary heart disease (CHD), not only with the low-density lipoprotein cholesterol (LDL-C) change in 1 year, but also the LDL-C Test on Target for 1 year. This study further aims to assess the adherence, treatment patterns and satisfaction, and safety of inclisiran among Chinese patients.
Study Start Date: April 30
Study Type: INTERVENTIONAL
Condition:
Coronary Heart Disease
Interventio...